Switzerland · Delayed Price · Currency is CHF Basilea Pharmaceutica AG Statistics
Total Valuation
SWX:BSLN has a market cap or net worth of CHF 828.30 million. The enterprise value is 738.69 million.
| Market Cap | 828.30M |
| Enterprise Value | 738.69M |
Important Dates
The last earnings date was Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:BSLN has 12.42 million shares outstanding. The number of shares has decreased by -1.46% in one year.
| Current Share Class | 12.42M |
| Shares Outstanding | 12.42M |
| Shares Change (YoY) | -1.46% |
| Shares Change (QoQ) | +2.14% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 35.46% |
| Float | 12.33M |
Valuation Ratios
The trailing PE ratio is 16.63 and the forward PE ratio is 15.27.
| PE Ratio | 16.63 |
| Forward PE | 15.27 |
| PS Ratio | 3.35 |
| PB Ratio | 5.10 |
| P/TBV Ratio | 5.11 |
| P/FCF Ratio | 14.98 |
| P/OCF Ratio | 14.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.72, with an EV/FCF ratio of 13.36.
| EV / Earnings | 14.10 |
| EV / Sales | 2.99 |
| EV / EBITDA | 11.72 |
| EV / EBIT | 12.34 |
| EV / FCF | 13.36 |
Financial Position
The company has a current ratio of 6.60, with a Debt / Equity ratio of 0.51.
| Current Ratio | 6.60 |
| Quick Ratio | 5.81 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 1.51 |
| Interest Coverage | 21.08 |
Financial Efficiency
Return on equity (ROE) is 39.46% and return on invested capital (ROIC) is 73.48%.
| Return on Equity (ROE) | 39.46% |
| Return on Assets (ROA) | 13.69% |
| Return on Invested Capital (ROIC) | 73.48% |
| Return on Capital Employed (ROCE) | 23.34% |
| Weighted Average Cost of Capital (WACC) | 6.30% |
| Revenue Per Employee | 1.24M |
| Profits Per Employee | 261,920 |
| Employee Count | 200 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 6.25 |
Taxes
In the past 12 months, SWX:BSLN has paid 6.29 million in taxes.
| Income Tax | 6.29M |
| Effective Tax Rate | 10.72% |
Stock Price Statistics
The stock price has increased by +44.69% in the last 52 weeks. The beta is 0.43, so SWX:BSLN's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +44.69% |
| 50-Day Moving Average | 56.99 |
| 200-Day Moving Average | 54.19 |
| Relative Strength Index (RSI) | 69.08 |
| Average Volume (20 Days) | 69,577 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:BSLN had revenue of CHF 247.42 million and earned 52.38 million in profits. Earnings per share was 4.01.
| Revenue | 247.42M |
| Gross Profit | 95.27M |
| Operating Income | 59.88M |
| Pretax Income | 58.68M |
| Net Income | 52.38M |
| EBITDA | 60.92M |
| EBIT | 59.88M |
| Earnings Per Share (EPS) | 4.01 |
Balance Sheet
The company has 173.05 million in cash and 83.44 million in debt, with a net cash position of 89.61 million or 7.22 per share.
| Cash & Cash Equivalents | 173.05M |
| Total Debt | 83.44M |
| Net Cash | 89.61M |
| Net Cash Per Share | 7.22 |
| Equity (Book Value) | 162.35M |
| Book Value Per Share | 13.09 |
| Working Capital | 232.29M |
Cash Flow
In the last 12 months, operating cash flow was 58.01 million and capital expenditures -2.71 million, giving a free cash flow of 55.30 million.
| Operating Cash Flow | 58.01M |
| Capital Expenditures | -2.71M |
| Depreciation & Amortization | 1.05M |
| Net Borrowing | n/a |
| Free Cash Flow | 55.30M |
| FCF Per Share | 4.45 |
Margins
Gross margin is 38.51%, with operating and profit margins of 24.20% and 21.17%.
| Gross Margin | 38.51% |
| Operating Margin | 24.20% |
| Pretax Margin | 23.72% |
| Profit Margin | 21.17% |
| EBITDA Margin | 24.62% |
| EBIT Margin | 24.20% |
| FCF Margin | 22.35% |
Dividends & Yields
SWX:BSLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.46% |
| Shareholder Yield | 1.46% |
| Earnings Yield | 6.32% |
| FCF Yield | 6.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SWX:BSLN is 105.37, which is 57.98% higher than the current price. The consensus rating is "Buy".
| Price Target | 105.37 |
| Price Target Difference | 57.98% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -4.54% |
| EPS Growth Forecast (3Y) | -24.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:BSLN has an Altman Z-Score of 1.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 6 |